Condition: Soft Tissue Injuries · Sponsor: IBSA Institut Biochimique SA
A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety of the Licart topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. To collect principal investigator-reported global response to therapy.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Applied Research Center | Little Rock, Arkansas, United States | — |
| Atella Clinical Research, LLC. | La Palma, California, United States | — |
| University Clinical Research - Deland, LLC | DeLand, Florida, United States | — |
| My Community Research, Inc. | Miami, Florida, United States | — |
| D & H Tamarac Research Centers, Inc. | Tamarac, Florida, United States | — |
| Research Integrity | Owensboro, Kentucky, United States | — |
| Ascendant Research Clinic, LLC. | Alamogordo, New Mexico, United States | — |
| Prime Global Research Inc. | The Bronx, New York, United States | — |
| Ascendant Research Clinic, LLC. | Marion, South Carolina, United States | — |
| Next Level Urgent Care | Houston, Texas, United States | — |
| AIM Trials | Plano, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05171673